Fingerprint
Dive into the research topics of 'Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial
Jan B. Vermorken, Anke M.E. Claessen, Harm Van Tinteren, Helen E. Gall, Renate Ezinga, Sybren Meijer, Rik J. Scheper, Chris J.L.M. Meijer, Elizabeth Bloemena, Janet H. Ransom, Michael G. Hanna, Herbert M. Pinedo
Research output: Contribution to journal › Article › peer-review
476
Citations
(Scopus)